eCTD format mandatory from 2010 at the EMEA
This article was originally published in SRA
The European Medicines Agency has added a new milestone to its plans to implement electronic-only marketing authorisation applications from drug companies in a standardised format under the centralised procedure1. From 1 January 2010, use of the electronic common technical document (eCTD) format will be mandatory for all new and existing submissions and for all submission types.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Existing importers and manufacturers of certain medical devices can continue marketing their products for six months or until the Indian medtech regulator makes a final decision on their pending licensing applications.
Differences between how Australia and the EU define “central circulatory system” has resulted in different risk classification levels being assigned to some devices in the two jurisdictions.